SCHEDULE: Jericho Capital Reports 7.2% Stake in Core Scientific

Jericho Capital Asset Management L.P. and Josh Resnick have reported beneficial ownership of 7.2% of Core Scientific, Inc.'s common stock as of June 30, 2026.

Summary

• Jericho Capital Asset Management L.P. and Josh Resnick have filed a Schedule 13G.
• They collectively beneficially own 22,882,942 shares of Core Scientific, Inc. common stock.
• This represents 7.2% of the class of securities.
• The filing indicates shared voting and dispositive power over these shares.
• Jericho Capital Asset Management L.P. acts as the investment adviser to funds holding these shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, as it primarily reports a change in beneficial ownership percentage and does not contain operational or financial performance updates.

Positives

• Jericho Capital Asset Management L.P. has a significant stake, indicating investor confidence or strategic interest.
• The filing is current as of June 30, 2026, providing up-to-date ownership information.

Negatives

• The filing does not provide any financial performance data or operational updates for Core Scientific, Inc.
• It does not offer insights into the strategic rationale behind the ownership stake.

Risks

• Concentration of ownership by a single entity could potentially influence corporate decisions.
• Changes in beneficial ownership can sometimes precede activist investor campaigns or strategic shifts.

Future Outlook

No forward-looking statements or guidance are provided in this filing.

Management Comments

• Jericho Capital Asset Management L.P. is the investment adviser to certain investment funds and accounts which have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the shares of Common Shares reported herein.
• The filing certifies that the securities were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer.

Industry Context

StockSavvy.ai notes that significant ownership stakes reported via Schedule 13G filings are common in the technology and cryptocurrency mining sectors, where consolidation and strategic investments can occur.

Stakeholder Impact

• Shareholders: The increased concentration of ownership by Jericho Capital may influence future corporate actions or strategic decisions.
• Management: The filing confirms a significant shareholder's position, which may impact board dynamics and strategic planning.

Next Steps

• Jericho Capital Asset Management L.P. and Josh Resnick will continue to hold their beneficial ownership stake.
• Amendments to this Schedule 13G will be filed as required by regulations.

Key Dates

Keywords

Core Scientific, Jericho Capital, Schedule 13G, Beneficial Ownership, Investment Management, Common Stock, Shareholder